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ARTICLE
Mini-dystrophin Expression Down-regulates IP3-mediated Calcium 
Release Events in Resting Dystrophin-deﬁ  cient Muscle Cells
Haouaria Balghi, Stéphane Sebille, Ludivine Mondin, Anne Cantereau, Bruno Constantin, 
Guy Raymond, and Christian Cognard
Institut de Physiologie et Biologie Cellulaires, CNRS UMR 6187, Université de Poitiers, 86022 Poitiers, France
We present here evidence for the enhancement, at rest, of an inositol 1,4,5-trisphosphate (IP3)–mediated calcium 
signaling pathway in myotubes from dystrophin-defi  cient cell lines (SolC1(−)) as compared to a cell line from the 
same origin but transfected with mini-dystrophin (SolD(+)). With confocal microscopy, the number of sites dis-
charging calcium (release site density [RSD]) was quantifi  ed and found more elevated in SolC1(−) than in 
SolD(+) myotubes. Variations of membrane potential had no signifi  cant effect on this difference, and higher rest-
ing [Ca2+]i in SolC1(−) (Marchand, E., B. Constantin, H. Balghi, M.C. Claudepierre, A. Cantereau, C. Magaud, 
A. Mouzou, G. Raymond, S. Braun, and C. Cognard. 2004. Exp. Cell Res. 297:363–379) cannot explain alone higher 
RSD. The exposure with SR Ca2+ channel inhibitors (ryanodine and 2-APB) and phospholipase C inhibitor 
(U73122) signifi  cantly reduced RSD in both cell types but with a stronger effect in dystrophin-defi  cient SolC1(−) 
myotubes. Immunocytochemistry allowed us to localize ryanodine receptors (RyRs) as well as IP3 receptors (IP3Rs), 
IP3R-1 and IP3R-2 isoforms, indicating the presence of both RyRs-dependent and IP3-dependent release systems 
in both cells. We previously reported evidence for the enhancement, through a Gi protein, of the IP3-mediated 
calcium signaling pathway in SolC1(−) as compared to SolD(+) myotubes during a high K+ stimulation (Balghi, 
H., S. Sebille, B. Constantin, S. Patri, V. Thoreau, L. Mondin, E. Mok, A. Kitzis, G. Raymond, and C. Cognard. 2006. 
J. Gen. Physiol. 127:171–182). Here we show that, at rest, these regulation mechanisms are also involved in the mod-
ulation of calcium release activities. The enhancement of resting release activity may participate in the calcium 
overload observed in dystrophin-defi  cient myotubes, and our fi  ndings support the hypothesis of the regulatory 
role of mini-dystrophin on intracellular signaling.
INTRODUCTION
Duchenne muscular dystrophy (DMD) is the most fre-
quent of genetic diseases (1 boy in 3,500) and affects all 
muscles (skeletal, smooth, and cardiac). This progres-
sive disease is characterized by the absence of  dystrophin 
due to a defect in the p21 band of the X chro    mosome 
(Monaco et al., 1986). Dystrophin is a 427-kD cyto-
skeletal protein normally expressed at the inner sur-
face of the sarcolemma of muscle fi  bers  (Hoffman 
et al., 1987) and associated with a large complex of 
  proteins known as the dystrophin-associated proteins 
(DAPs) (Ervasti and Campbell, 1991). In 1955, Becker 
and Kiener  described another form of progressive mus-
cular dystrophy, the Becker muscular dystrophy (BMD), 
associated later with the expression of a truncated 
229-kD protein, namely mini-dystrophin. It has been 
shown that the small size of the gene encoding for mini-
dystrophin facilitated its expression via a retroviral 
  vector,   allowing functional recovery in mdx mice 
  (Deconinck et al., 1996).
In DMD patients, the lack of dystrophin leads to mus-
cle degeneration and progressive weakness. It was pro-
posed that, in dystrophic cells, absence of dystrophin 
leads to abnormal elevation of the cytosolic resting cal-
cium level (Bodensteiner and Engel, 1978; Imbert et al., 
1995). How the absence of dystrophin leads to the 
  cytosolic calcium overload at the origin of the extensive 
muscle degeneration at the late stages of DMD is still 
poorly understood. Presently, there is little data con-
cerning a possible role of Ca2+ stored in the SR in cal-
cium mishandling observed in dystrophic cells (Liberona 
et al., 1998). Furthermore, modifi  cations in the regula-
tion of internal calcium stores have been suggested to 
be involved in the general calcium disregulation in 
DMD (Divet and Huchet-Cadiou, 2002; Vandebrouck 
et al., 2002).
Excitation–contraction coupling in skeletal muscle 
takes place by release of stored calcium from the SR via 
ryanodine receptors (RyRs). This release is triggered by 
an allosteric signal transmitted to the release channels 
from the dihydropyridine receptors (DHPRs) (Rios and 
Pizarro, 1991; Ursu et al., 2001; Lorenzon et al., 2004). 
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The presence of IP3 receptors in cultured muscle 
(Liberona et al., 1998, Powell et al., 2001) and in adult 
skeletal muscle (Moschella et al., 1995, Salanova et al., 
2002) also suggests a role for IP3 signals in both nuclear 
and cytoplasmic compartments. These cascades result 
in the up-regulation of gene activity (Powell et al., 2001, 
Carrasco et al., 2003). An IP3 signaling pathway, which 
depends on the voltage sensor of the DHPR, was then 
proposed in cultured muscle (Araya et al., 2003, Eltit 
et al., 2006).
Previous studies have shown signifi  cant local quantal 
Ca2+ release events at rest using laser scanning confocal 
fl   uorescence microscopy (Cheng et al., 1993). RyR 
channels are known to contribute to these events (Lipp 
and Niggli, 1994; Mackenzie et al., 2001), and their con-
certed opening and closing result in a miniature Ca2+ 
release event called a spark (Lacampagne et al., 1998; 
Shirokova et al., 1999; Conklin et al., 2000; Kettlun et al., 
2003). In mammals, Ca2+ sparks have been described 
in smooth muscle (Mironneau et al., 1996; Gordienko 
et al., 1998; Jaggar et al., 2000), cardiac muscle (Niggli, 
1999; Cordeiro et al., 2001; Lipp et al., 2002), and skele-
tal muscle cells (Cheng et al., 1999; Shirokova et al., 
1999; Zhou et al., 2003). In smooth muscle cells, sites 
of spontaneous Ca2+ sparks may coincide with sites of 
IP3-induced Ca2+ release, suggesting possible intercom-
munication between RyRs and IP3Rs in functional 
  microdomains (Gordienko and Bolton, 2002; Zhang 
et al., 2003). In cardiac muscle, spatio-temporal recruit-
ment of Ca2+ sparks underlies the global Ca2+ signal 
that subsequently activates myocyte contraction. In 
these cells, activation of IP3Rs that colocalize with RyRs 
(Lipp et al., 2000) causes the appearance of spontane-
ous subsarcolemmal Ca2+ sparks (Bootman et al., 2002; 
Mackenzie et al., 2002). In developing or mature skele-
tal muscle cells, it is still unknown if IP3Rs could con-
tribute in the initiation and/or propagation of 
spontaneous calcium release events.
In our previous works using a Sol cell line, intrinsi-
cally lacking dystrophin (Sol8 or SolC1(−)), we had 
  selected stable Sol8 subclones, SolD(+), which con-
stitutively express the BMD mini-dystrophin (Marchand 
et al., 2004). Myotubes from the SolC1(−) cell line 
  exhibited morphological signs of cell death during 
myogenesis in culture, in parallel with an alteration of 
Ca2+ homeostasis. Furthermore, expression of BMD 
mini-dystrophin restored sarcolemmal expression and 
location of several members of the DAPs complex and 
allowed these cells to recover an intracellular Ca2+ con-
centration closer to myotubes from mouse primary cell 
culture. We also reported evidence for the enhance-
ment of the IP3-mediated calcium signaling pathway in 
SolC1(−) as compared with SolD(+) myotubes (Balghi 
et al., 2006). These previous experiments were per-
formed in myotubes stimulated with perfusion of a solu-
tion containing high potassium concentration. Global 
calcium rise observed in this stimulation condition de-
pended on two mechanisms of SR calcium release: a fast 
SR calcium release, dependent on the RyRs, and a slow 
release, mediated by IP3Rs. We further demonstrated 
that the slow release, depending on the regulation of a 
Gi protein, was increased in the SolC1(−) as compared 
with the SolD(+) myotubes.
Here we show that the regulation mechanisms de-
scribed above during stimulation are also involved in 
the modulation of resting calcium release. With the use 
of a parameter describing the density of release sites, a 
pattern of resting release sites was found to be different 
in dystrophin-defi  cient  SolC1(−) myotubes and in 
SolD(+) ones. Experiments conducted in this work 
demonstrate a modulatory effect of mini-dystrophin, at 
rest, on spontaneous events of calcium release that de-
pends on the IP3 signaling pathway.
MATERIALS AND METHODS
Cell lines
Sol8 myogenic cell line (a gift from I. Martelly, University of Paris 
XII, Creteil, France) derived from the Sol8 cell line originally ob-
tained from primary culture of normal C3H mouse soleus muscle 
(Mulle et al., 1988). The method for obtaining cell lines (SolC1(−) 
and SolD(+)) was described elsewhere (Marchand et al., 2004). 
In brief, after several steps of cloning, a dystrophin-defi  cient cell 
line was obtained, named SolC1(−). The SolD(+) cell line was 
obtained by transfection of the SolC1(−) cell line with a retrovi-
rus encoding for mini-dystrophin (229 kD). SolC1(−) and 
SolD(+) cell lines (“Sol” cell lines in the following text) maintain 
a high ability to fuse and form myotubes. Cells were seeded on 
gelatin-coated glass coverslips in plastic dishes. Myoblasts were 
grown to  80% confl  uence in HamF12/DMEM (1:1) medium 
supplemented with 10% FCS, 1% l-glutamine, and 1% antibiot-
ics. To induce differentiation, the growth medium was changed to 
a fusion medium (DMEM supplemented with 2% heat inactivated 
horse serum, insulin [10 μg/ml, Sigma-Aldrich], 1% l-glutamine, 
and 1% antibiotics). Experiments were performed at the stage of 
F+4 (4 d after addition of fusion medium) for SolC1(−) and 
SolD(+) myotubes.
Confocal Ca2+ Measurement
Ca2+ activity was recorded by confocal laser scanning microscopy 
using a Bio-Rad Laboratories MRC 1024 equipped with a 15-mW 
Ar/Kr gas laser. The confocal unit was attached to an inverted 
  microscope (Olympus IX70). Fluorescence signal collection was 
performed through the control software Lasersharp 3.2 (Bio-Rad 
Laboratories). Myotubes were loaded with 3 μM fl  uo-4 acetoxy-
methyl (AM) ester (Molecular Probes) for 15 min at room tem-
perature (20°C) in a resting solution (130 mM NaCl, 5.4 mM KCl, 
2.5 mM CaCl2, 0.8 mM MgCl2, 10 mM HEPES, and 5.6 mM 
  glucose, pH 7.4).
Two types of experiments have been performed. First, Ca2+ 
sparks were identifi  ed on two-dimensional images (512 × 512 pix-
els) with a 60× oil immersion objective (1.4 numerical aperture) 
and were acquired in line scan mode (x,t images: 1 line/2 ms, 
512 × 512 pixels) taking fl  uorescence variations along a space 
line as a function of time. Second, density of release sites was 
  obtained by recording sequences of 30–50 images (256 × 256 pixels) 
with a 20× objective in fast scanning mode. The time resolution 
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Ryanodine (Sigma-Aldrich) was incubated at 100 μM for 10 
min to inhibit RyRs. For IP3 inhibition studies, myotubes were in-
cubated for 30 min in 50 μM 2-APB (Calbiochem) or for 20 min 
in the presence of 10 μM U73122 (Sigma-Aldrich). Pertussis toxin 
(Calbiochem) was incubated at 1 μg/ml for 1 h.
Intracellular Calcium Concentration Measurements
Intracellular free calcium measurements were performed by 
means of a ratiometric fl  uorescence method using an OSP100 mi-
croscopic photometry system (Olympus) and the calcium fl  uores-
cent probe Indo-1. The ratiometric method and the calibration 
procedure have been published elsewhere (Grynkiewicz et al., 
1985; Cognard et al., 1993). The two emission fl  uorescence values 
of the free and Ca2+-bound forms of Indo-1 (at 485 and 405 nm, 
respectively) were separated, fi  ltered, and collected by two photo-
multipliers. The intracellular free calcium concentrations were 
calculated from the following equation: [Ca2+]i  = Kd ×  β  × 
[(R − Rmin)/(Rmax − R)] (Grynkiewicz et al., 1985). All the ex-
periments were performed at room temperature. In brief, cells 
were rinsed with standard external solution (130 mM NaCl, 5.4 
mM KCl, 2.5 mM CaCl2, 0.8 mM MgCl2, 10 mM HEPES, 5.6 mM 
d-glucose, pH 7.4 with NaOH) and incubated for 45 min at room 
temperature in the same solution supplemented with 3 μM (fi  nal 
concentration) of the acetoxy-methyl ester form of Indo-1 (Indo-1/
AM; Sigma-Aldrich). BAPTA-AM (Sigma-Aldrich) was used at dif-
ferent concentrations: 100 nM, 300 nM, 1 μM, 3 μM, and 10 μM.
Image Processing
Calcium images were analyzed with two different computer programs 
developed in our laboratory under IDL 5.3 structured language.
Line-scan Image Processing. Ca2+ sparks were analyzed using the 
HARVELE software (Sebille et al., 2005), which automatically de-
tects local Ca2+ release events on a series of x,t images. For each 
spark, fi  ve parameters were determined: ΔF/F0 (normalized max-
imum amplitude of fl  uorescence), rise time (RT) in ms, FWHM 
(full width at half maximum) in μm, FDHM (full duration at half 
maximum) in ms, and frequency in sparks/s. The frequency pa-
rameter represents here the frequency of the occurring of several 
events in each site measured with line scan recording and reveals 
the intrinsic kinetics properties of releasing sites. Parameters were 
represented as distribution histograms.
Density of Release Sites. Sequences of images in fast mode were 
analyzed with a program allowing us to calculate the standard de-
viation of the recorded fl  uorescence in each pixel as a function of 
time. During the acquisition sequence, when several releases were 
observed in the same location, the calculated standard deviation 
of pixels in this location was higher than in areas without calcium 
increase. The result obtained was an image with discrete spots of 
elevated standard deviation (see Results and Fig. 3) on which it 
was easy to count the number of release sites in the sequence. 
From that process a parameter can be derived that describes the 
density of release sites in myotubes: the number of events/μm2 
(in μm−2).
Immunological Staining
Cultured cells were stained by an indirect immunofl  uorescence 
method. Cells were rinsed in TBS (20 mM Tris base, 154 mM 
NaCl, 2 mM EGTA, 2 mM MgCl2, pH 7.5) and fi  xed with either 
4% paraformaldehyde (PFA) in TBS for 20 min or methanol 
(stored at −20°C) for 6 min, at room temperature. Only sam-
ples fi  xed with PFA were permeabilized with TBS/0.5% Triton 
X-100 for 10 min. Calbiochem supplied the anti-RyR. Affi  nity 
Bioreagents supplied the anti–IP3R-1 (the same was used for 
Western blot) and the anti–IP3R-2 epitope affi  nity–purifi  ed 
polyclonal antibodies (1:250, PA1-901 and 1:100, PA1-904 
  respectively). No commercial anti–IP3R-3 antibody was avail-
able for us to perform immunolocalization of this isotype. Cells 
were incubated with primary antibodies in TBS/1% BSA (Sigma-
Aldrich) for 1 h. After washing in TBS, cells were incubated for 
30 min with the secondary antibody Rhodamine red-X (RRX) 
conjugated goat anti-  rabbit (1:200, Jackson ImmunoResearch 
Laboratories) and/or secondary antibody FITC-conjugated goat 
anti-mouse (1:200, Jackson ImmunoResearch Laboratories). 
Samples were mounted in Vectashield Medium (Vector Labora-
tories, Inc.) for viewing with a confocal laser scanning micro-
scope using a Bio-Rad Laboratories MRC 1024. Immunostaining 
images were processed (no gamma adjustment) and assembled 
in Powerpoint 2000.
Statistical Analysis
All results are expressed as mean ± SEM of n observations. Sets of 
data were compared using Student’s t test. All statistical tests were 
performed using GraphPad Prism version 3.0 or 4.0 for Windows 
(GraphPad Software).
RESULTS
Morphology of Calcium Release Events in Sol Cells
In previous experiments, several calcium release prop-
erties were revealed in myotubes from the dystrophin-
defi  cient SolC1(−) cell line and the SolD(+) cell line 
(expressing mini-dystrophin). First, fl  uo-4–loaded 
SolC1(−) myotubes exhibited large calcium release 
and spontaneously propagating Ca2+ waves (Marchand 
et al., 2004). Second, we demonstrated that global cal-
cium rise, induced by the perfusion of a solution con-
taining a high potassium concentration, was higher in 
SolC1(−) than in SolD(+) myotubes (Balghi et al., 
2006). Finally, in recent observations, both cell types 
displayed spontaneously discrete release events at rest 
with very different apparent activity between the two 
cell types. The aim of the present study was to examine 
resting release events recorded in SolC1(−) and 
SolD(+) myotubes in order to compare them in the two 
cell types.
After incubation of myotubes with fl  uo4-AM, Ca2+ re-
lease events were localized on x,y images and were re-
corded in a line scan mode (x,t images). These events 
were analyzed using the HARVELE software developed 
in our lab (Sebille et al., 2005) that fi  rst allows an auto-
mated detection of signals in x,t images and second cal-
culates morphological parameters of each detected 
event. Fig. 1 displays examples of line-scan recordings 
in SolC1(−) (Fig. 1 A) and in SolD(+) myotubes (Fig. 
1 B). Fig. 1 (C and D) illustrates the software process 
for measuring morphological parameters. For each 
  selected spark, four morphological parameters were 
  determined: the normalized difference between the 
fl  uorescence of the peak and the background (∆F/F0: 
amplitude), the rise time (RT in ms) (Fig. 1 C), the 
FDHM (in ms) and the FWHM (in μm) (Fig. 1 D). 
These parameters were collected from events recorded 
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and then sorted for a representation of histogram 
  distribution (Fig. 2). Distributions of spark amplitude, 
duration, and size were found unsymmetrical due to 
the inherent property of off-center sampling in line-
scan confocal imaging. Parameters from the two popu-
lations of events were then compared with the 
nonparametric Mann-Whitney U test. It is also worth 
noting that small events (with amplitude value <0.3) 
were deliberately deselected, due to the measurement 
errors on these low and noisy signals. Hence, the non-
modal distribution, theoretically demonstrated and 
found when all sparks are selected (Cheng et al., 1999), 
was not obtained in our results. With the statistical test, 
calcium release event duration (FDHM) was found 
slightly longer in SolC1(−) than in SolD(+) (SolC1(−): 
median = 64.5 ms; SolD(+): median= 55.2 ms; P = 
0.009). The spread (FWHM) was also slightly higher in 
SolC1(−) than in SolD(+) (SolC1(−): median= 3.31 
μm; SolD(+): median = 3.00 μm; P < 0.001). No sig-
nifi  cant differences were found between the two cell 
types in amplitude (SolC1(−): median = 0.82; SolD(+): 
median = 0.80; not signifi  cantly different [ns]), rise 
time parameter (SolC1(−): median = 44.00 ms; 
SolD(+): median = 44.10 ms; ns), as well as the fi  fth 
measured parameter, the frequency (SolC1(−): 1.87 
s−1; SolD(+): 1.83 s−1). Therefore, this analysis indi-
cates that Ca2+ calcium release events occurring at rest 
in SolC1(−) displayed similar morphological proper-
ties to those in SolD(+) myotubes.
SolC1(−) Exhibited More Sites of Calcium Release 
than SolD(+)
In our preliminary experiments, we observed that the 
number of sites discharging calcium was more elevated 
in SolC1(−) than in SolD(+) myotubes. To quantify 
this difference, time sequences of fast confocal images 
have been recorded in fl  uo-4–loaded myotubes from 
both cell types. Hence, in each sequence, 30–50 fl  uores-
cence images with 300-ms time resolution (time be-
tween two fl   uorescence acquisitions for each pixel 
position) were recorded on the same microscope fi  eld 
in myotube preparations. As examples, Fig. 3 (A and B) 
displays two different fast-recorded images extracted 
from a sequence with spots of fl  uorescence in two dis-
tinct myotubes (as shown with white arrows). Each spot, 
corresponding to a localized calcium release event, is 
observed in one image of the sequence, and several 
events can originate from the same location in the fi  eld 
during the acquisition sequence. Sequences of images 
in fast mode were analyzed with a program allowing us 
to calculate the standard deviation of the recorded fl  uo-
rescence in each pixel as a function of time. During the 
acquisition sequence, when several releases were ob-
served in the same location, the calculated standard 
Figure 1.  Examples of line-scan 
  recordings in SolC1(−) (A) and 
in SolD(+) (B) fl  uo-4–loaded myo-
tubes. Space bar (x), 5 μm. Time 
bar (t), 100 ms. A selected area dur-
ing the detection is indicated by the 
white square in A. C and D illustrate 
the software process for measuring 
morphological parameters on se-
lected areas. For each selected 
event, fi  ve parameters were deter-
mined: the normalized difference 
between the fl   uorescence of the 
peak and the background (∆F/F0: 
amplitude), the rise time (RT in 
ms), the FDHM (in ms), the FWHM 
(in  μm), and the frequency. 
(C) Profi  le of one spark in a three-
  dimensional representation (shaded 
surface) indicating rise time 
(RT) and fl  uorescence amplitude. 
(D) The white contour represents 
the half maximum slide on which 
the FWHM and the FDHM (view 
from the top) are measured.  Balghi et al. 223
  deviation of pixels in this location was more elevated as 
compared with areas without calcium increase. The re-
sult obtained was an image with discrete spots of ele-
vated standard deviation (Fig. 3 C) on which it was easy 
to visually count the number of sites of release in the se-
quence. From that process, a parameter can be derived 
that describes the density of calcium release sites in 
myotubes (RSD in the following text): the number of 
sites/μm2 (in μm−2). At rest, in physiological condi-
tions corresponding to a 5.4 mM external potassium 
concentration, SolC1(−) and SolD(+) myotubes ex-
hibited 1.43 ± 0.17 10−4 and 0.72 ± 0.12 10−4 sites/
μm2, respectively. Further experiments have then been 
performed to explore these differences.
Membrane Potential and Density of Release Sites
To understand a possible role of membrane potential in 
these activities, RSD was measured with various extracellu-
lar [K+] solutions, known to modify membrane potential 
of myotubes. Perfusion of low extracellular K+ solutions 
(2 mM: hyperpolarizing solution) or high K+ solutions 
(10 and 20 mM: depolarizing solutions) only weakly modi-
fi  ed the number of sites/μm2 in SolC1(−) and SolD(+) 
myotubes. In each case, SolC1(−) exhibited higher values 
than SolD(+) myotubes (Fig. 4). With the patch clamp 
technique, application of a current clamp protocol for 
measuring membrane potential in whole cell confi  gura-
tion demonstrated both similar resting potentials in 
SolC1(−) and SolD(+) and confi  rmed hyperpolarizing 
and depolarizing effects of perfusions (unpublished data). 
Variations of membrane potential had no signifi  cant ef-
fects on RSD in our cellular models. Moreover, no change 
in calcium release event frequency has been detected dur-
ing these experiments (unpublished data).
Effect of Calcium Levels on Resting Calcium Release 
Site Density
Previous results demonstrated higher resting [Ca2+]i in 
SolC1(−) myotubes as compared with SolD(+) myo-
tubes (Marchand et al., 2004), and it is also well known 
that calcium release channels are calcium sensitive. To 
determine if such elevated calcium levels in dystrophin-
defi  cient cells could explain per se a higher RSD, ex-
periments with modifi  ed resting [Ca2+]i were conducted. 
Myotube preparations were incubated with various con-
centrations of BAPTA-AM (100 nM, 300 nM, 1 μM, 3 μM, 
and 10 μM), maintaining various calcium levels by 
  chelating different amounts of intracellular free Ca2+. 
Subsequently, two sets of experiments were performed 
as follows. First, intracellular free calcium concentra-
tions were determined with a ratiometric fl  uorescence 
method using a microscopic photometry system and the 
calcium probe Indo-1. Second, density of release sites 
was measured with confocal microscopy and fl  uo-4. 
Both sets of experiments were performed in each 
BAPTA-AM incubation condition and Fig. 5 depicts 
measured RSD as a function of [Ca2+]i in both SolC1(−) 
and SolD(+) myotubes. Starting from the control con-
ditions, incubation with increased [BAPTA-AM] in both 
myotube types resulted in a decrease of resting [Ca2+]i 
(50 nM [Ca2+]i with 10 μM chelator). The density of 
calcium release events, which was more elevated in 
Figure 2.  Characterization of calcium event morphology in myo-
tubes from SolC1(−) and SolD(+). Distribution Histograms of 
∆F/F0 (A), FDHM (B), RT (C), and FWHM (D) of calcium events 
identifi  ed in SolC1(−) (gray bars, n = 733) and SolD(+) (black 
bars, n = 280) myotubes. Each bin includes the upper value. For 
illustrative purposes, distributions were fi  tted by Gaussian pro-
fi  les. Median values were calculated and differences were evalu-
ated with the nonparametric Mann-Whitney U test. Coeffi  cient 
variations for distributions were as follows: SolC1(−):  ∆F/F0, 
42%; FDHM, 63%; RT, 52%; FWHM, 31%; and SolD(+): ∆F/F0, 
28%; FDHM, 62%; RT, 49%; FWHM, 35%.224 Calcium Release Events in Dystrophin-deﬁ  cient Cells
SolC1(−) (squares) than in SolD(+) (triangles) in con-
trol conditions (arrows), was reduced in both cells when 
[BAPTA-AM] was increased in the incubation medium. 
It is also worth noting that in both cells, RSD measured 
in controls was maintained even when a signifi  cant re-
duction in [Ca2+]i was observed. For example, in 
SolC1(−), the same RSD value was observed at 80 nM 
[Ca2+]i and 140 nM [Ca2+]i (control). At lower concen-
trations, event density was strongly reduced within a 
short concentration window (20 nM) and the same low 
RSD value was reached in both cells at low [Ca2+]i levels 
(50 nM). Nevertheless, sigmoid patterns of calcium re-
lease event site extinction were different between the 
dystrophin-defi  cient  SolC1(−) and the mini-dystro-
phin–transfected SolD(+) cells. Indeed, RSD decreased 
at [Ca2+]i lower than 85 nM and 95 nM in SolC1(−) 
and SolD(+), respectively, and the half-extinction 
[Ca2+]i value was 60 nM and 80 nM for SolC1(−) and 
SolD(+), respectively. These results indicated on the 
one hand that the amount of myoplasmic free calcium 
had an effect on calcium release event activity in chang-
ing the number of calcium release sites. On the other 
hand, because the calcium-dependent extinction pat-
tern (due to an increased [BAPTA]) was different be-
tween SolC1(−) and SolD(+) myotubes, the higher 
RSD in SolC1(−) in physiological conditions could not 
be explained by a causal effect of elevated resting [Ca2+]i 
alone. Finally, these curves demonstrate a more elevated 
Ca2+ sensitivity of calcium release event activity in dys-
trophin-defi  cient myotubes as compared with myotubes 
expressing mini-dystrophin.
The “Release Site Density” Parameter Was Modiﬁ  ed 
with the Use of SR Channel Blockers
To determine which types of calcium release channels 
are involved in calcium release events signaling in Sol 
cells, several Ca2+ release channel inhibitors were ap-
plied in our preparations and RSD was measured (Fig. 
6). To completely inhibit Ca2+ release through RyRs, 
  ryanodine was used at 100 μM (Gordienko and Bolton, 
2002). Exposure of SolD(+) myotubes to ryanodine for 
10 min almost abolished the spontaneous calcium RSD 
(Fig. 6 A). The same exposure of SolC1(−) myotubes to 
ryanodine instead spared a substantial density of events. 
These results suggest, fi  rst, a strong sensitivity of the 
density of calcium release events to ryanodine in SolD(+) 
myotubes and, second, that a ryanodine-insensitive 
Figure 3.  Density of release sites in myotubes from SolC1(−) and SolD(+). Time sequences of 30–50 fast confocal images (1 image every 
300 ms) have been recorded in fl  uo-4–loaded myotubes from both cell types. (A and B) Two different fast-recorded images extracted from 
a sequence with spots of fl  uorescence in two distinct myotubes (as indicated by white arrows). Each spot corresponds to a localized calcium 
release event. Sequences of images in fast mode were analyzed with a program allowing us to calculate the standard deviation of the recorded 
fl  uorescence in each pixel as a function of time. (C) Image resulting from this analysis. From that process, the number of sites was counted 
and the density of calcium release sites (i.e., the number of sites/μm2 [in μm−2]) was determined for both Sol myotubes. Bar, 15 μm.
Figure 4.  Membrane potential and density of release site. RSD 
was measured with various extracellular [K+] solutions, known to 
modify membrane potential in SolC1(−) (squares) and SolD(+) 
(triangles) myotubes. Perfusion of low extracellular K+ solutions 
(2 mM: hyperpolarizing solution) or high K+ solutions (10 and 
20 mM: depolarizing solutions) weakly modifi  ed the number of 
sites/μm2 in SolC1(−) and SolD(+) myotubes. In each case, 
SolC1(−) exhibited higher values than SolD(+) myotubes (Fig. 4). 
For each point, the number of myotubes analyzed is given near 
the symbol. Variations of membrane potential had no signifi  cant 
effect on RSD in our cellular models.  Balghi et al. 225
component of calcium release channels could be in-
volved particularly in SolC1(−) myotubes. We also 
tested the effect of thapsigargin, an inhibitor of the SR 
Ca2+-ATPase, on ryanodine-treated Sol cells. In both 
cells, the subsequent increase of calcium, refl  ecting the 
amount of calcium stored in the SR, was similar in 
  ryanodine-treated and untreated cells (unpublished 
data), indicating that the main effect of ryanodine 
in our treatment condition was the blockade of RyR 
  calcium channels.
Surprisingly, application of IP3 pathway inhibitors also 
reduced the RSD value in both SolC1(−) and SolD(+) 
myotubes. Incubation with 50 μM 2-APB, a direct inhibi-
tor of IP3 receptors, reduced RSD in both myotubes, but 
particularly in SolC1(−) myotubes (88% decrease, Fig. 
6 B, white bars). An identical level of RSD parameter was 
reached with 2-APB application on SolD(+) myotubes 
(76% decrease, Fig. 6 B, black bars). A similar decrease 
was obtained after incubation with the use of a PLC in-
hibitor (U73122: 10 μM) in both SolC1(−) and SolD(+) 
myotubes. Furthermore, combination of ryanodine and 
2-APB completely inhibited calcium release events in 
both myotubes (unpublished data).
These functional observations raised questions re-
garding (a) the involvement of IP3 receptors in the cal-
cium release events signaling occurring at rest and (b) 
an overactivation of this IP3 signaling pathway in dystro-
phin-defi  cient myotubes.
Immunolocalization of Involved SR Calcium Channels
Immunostaining experiments have been conducted in 
order to localize SR calcium channels that could be in-
volved in these release activities. As shown previously 
(Marchand et al., 2004), RyRs appeared randomly dis-
tributed in Sol myotubes (Fig. 7, A and D) without any 
alignment on transversal sarcomerization as in fi  bers. 
The same distribution of RyRs was observed in SolD(+) 
myotubes (Fig. 7 B) and in SolC1(−) myotubes (Fig. 7 A). 
Furthermore, in the same myotubes, immunostaining 
with antibodies against the isotype 2 of IP3R showed 
a peripheral and fully cytoplasmic localization in 
SolC1(−) (Fig. 7 C) and in SolD(+) (Fig. 7 D). As shown 
by yellow arrows, it is worth noting that locations with 
Figure 5.  Release site density as a function of intracellular cal-
cium concentration. The number of calcium release sites was de-
termined using confocal microscopy in SolC1(−) and SolD(+) 
myotubes incubated with fl  uo-4-AM and different concentrations 
of BAPTA-AM. Intracellular calcium concentrations were also de-
termined in SolC1(−) and SolD(+) myotubes, in the same 
BAPTA-AM conditions using cytofl  uorimetry technique and the 
Ca2+ probe Indo-1. Then, RSD obtained for each BAPTA concen-
tration was reported as a function of the intracellular calcium 
concentration in SolC1(−) (squares) and SolD(+) (triangles) 
myotubes. For each point, the number of myotubes analyzed is 
given near the symbol. BAPTA-AM concentrations were 100 nM, 
300 nM, 1 μM, 3 μM, and 10 μM incubated for 20 min, as illus-
trated by a large gray arrowhead on the graph. Data were fi  tted 
using Boltzmann equation (black and gray lines).
Figure 6.  Effects of ryanodine (100 μM), U73122 (10 μM), and 
2-APB (50 μM) on density of release sites. (A) Effects of treatment 
with ryanodine, incubated at 100 μM for 10 min, on the density of 
calcium release sites in SolC1(−) (white bars) and SolD(+) 
(black bars) myotubes. (B) Effect of treatment with U73122 (in-
cubated at 10 μM for 20 min) or 2-APB (incubated at 50 μM for 
30 min) on RSD in SolC1(−) (white bars) and SolD(+) (black 
bars). SolC1(−): control, n = 251; ryanodine, n = 178; 2-APB, 
n = 195; U73122, n = 213. SolD(+): control, n = 185; ryanodine, 
n = 193; 2-APB, n = 189; U73122, n = 177. ns, not signifi  cantly 
different. ***, P < 0,001; **, 0.001 ≤ P < 0,01; *, 0.01 ≤ P < 0.05 
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elevated staining for IP3R-2 correspond to areas with 
low staining for RyR in both SolC1(−) (Fig. 7, compare 
B with A) and SolD(+) myotubes (Fig. 7, compare E 
with D). This suggests that in these myotubes in matura-
tion, RyRs and IP3Rs could be situated in different and 
spatially segregated internal membranes. A clear  staining 
of IP3R-1, as shown in primary mouse cultures (Powell 
et al., 2001), was found in SolC1(−) myotubes (Fig. 7 E). 
The major part of the staining was observed in the 
  nuclear envelope region (localized around nuclei 
loaded with the fl  uorescent TO-PRO-3 probe) and a mi-
nor part in the myoplasm. In SolD(+) myotubes (Fig. 7 F), 
IP3R-1 was also localized in the nuclear envelope region, 
but the staining was fainter than in SolC1(−). These 
qualitative data demonstrate that IP3R-1 and IP3R-2 are 
expressed in SolC1(−) and SolD(+) myotubes. Unfor-
tunately, we were not able to localize the third isoform 
with the available IP3R-3 antibodies.
These immunocytochemistry analyses, combined with 
previous results obtained with RT-PCR and Western blot 
(Balghi et al., 2006), reveal the presence of a potential 
IP3-dependent calcium release system. The above data 
indicate the presence of an IP3-mediated system of cal-
cium release in both SolC1(−) (lacking dystrophin) 
and SolD(+) (expressing mini-dystrophin) myotubes, 
this system playing a role in intracellular calcium ho-
meostasis not only during stimulation (Balghi et al., 
2006) but also continuously at rest.
DISCUSSION
We performed experiments in this study on two types 
of myotubes originating from the same Sol8 cell line 
(Marchand et al., 2001): (1) dystrophin-defi  cient myo-
tubes, SolC1(−) and (2) myotubes transfected to ex-
press the BMD mini-dystrophin, SolD(+). When 
mini-dystrophin was restored, it was observed that, fi  rst, 
the members of the DAPs complex were readdressed 
and, second, intracellular Ca2+ levels were found simi-
lar to those observed in myotubes from mouse primary 
cell culture (Marchand et al., 2004). This model allows 
the physiological exploration of two cellular systems 
with the only difference being the presence (or not) of 
mini-dystrophin.
We have demonstrated that signaling of resting 
release events was different in dystrophin-defi  cient 
Figure 7.  Immunolocalization of RyRs and IP3Rs in SolC1(−) and SolD(+) myotubes. Immunolabelings of SR calcium release channels 
in SolC1(−) (A–C) and in SolD(+) myotubes (D–F) were observed with laser scanning confocal microscopy (LSCM). The same random 
distribution of RyRs (anti-RyR; Calbiochem) was observed in SolC1(−) myotubes (A) and in SolD(+) myotubes (D). In the same myo-
tubes, immunostaining with antibodies against IP3R-2 was performed in SolC1(−) (B) and in SolD(+) (E). Yellow arrows, locations cor-
responding to elevated staining for IP3R-2 and low staining for RyR. IP3R-1 staining is localized in the nuclear envelope region and in 
the cytoplasm in SolC1(−) (C) and in SolD(+) (F) myotubes. Insets, staining of selected nuclei (dotted squares) loaded with the fl  uores-
cent TO-PRO-3 probe. IP3R-1 and IP3R-2 localizations were detected using polyclonal antibodies, PA1-901 and PA1-904, respectively.  Balghi et al. 227
SolC1(−) and in SolD(+) myotubes. The number of 
sites discharging calcium, quantifi  ed with the RSD pa-
rameter was more elevated in SolC1(−) than in SolD(+) 
myotubes. Variations of membrane potential had no 
signifi   cant effect on RSD and differences in resting 
[Ca2+]i alone (Marchand et al., 2004) cannot explain 
higher RSD in SolC1(−) myotubes. Blockade of IP3 
pathway signifi  cantly reduced RSD in both cell types 
but with a stronger effect in dystrophin-defi  cient 
SolC1(−) myotubes. Immunocytochemistry allowed us 
to localize RyRs as well as IP3R-1 and IP3R-2 isoforms, 
indicating the presence of both RyR-dependent and 
IP3-dependent release systems in the Sol cells. We previ-
ously reported evidence for the enhancement of the 
IP3 mediated calcium signaling pathway in SolC1(−) as 
compared with SolD(+) myotubes (Balghi et al., 2006). 
We demonstrated that, with a high K+-stimulation, an 
IP3-dependent slow release, depending on the regula-
tion of a Gi protein, was increased in the SolC1(−) as 
compared with the SolD(+) myotubes. Here we show 
that, at rest, these regulation mechanisms are also in-
volved in the modulation of calcium release activities. 
The enhancement of RSD could then play a signifi  cant 
role in the calcium overload observed in dystrophin 
  defi  cient myotubes.
Quantiﬁ  cation and Modulation of Calcium Release 
Event Activity
Most of the experiments presented here were motivated 
by the observation, at rest, of numerous release events 
in fl  uo-4–loaded SolC1(−) myotubes. Moreover, under 
the same conditions, spark-like events were very rare in 
both SolD(+) and primary culture myotubes (unpub-
lished data). This difference was more easily observed 
in recording fast x-y images with a 20× objective. This 
kind of recording contains 30–50 images with 300-ms 
time resolution (time between two fl  uorescence acquisi-
tions for each pixel position, i.e., for each location in 
myotubes). We observed that such experiments allowed 
us to capture events from all sites of release because of 
the long overall time of recording (10–15 s), but all the 
events from sites may not be captured. Indeed, one 
event with duration of several tens of milliseconds may 
occur during a 300-ms gap between two images, making 
it nonrecordable. To quantify the observed difference, 
a tool for image analysis, based on standard deviation 
measurements, has been developed in the laboratory to 
count the number of calcium release sites (RSD). This 
analysis, associated with complementary morphological 
studies, provided a complete overview of the properties 
of spontaneous release events in Sol myotubes.
Previous studies in smooth muscle showed that changes 
in membrane potential modulate both frequency and 
amplitude of Ca2+ release events (Jaggar et al., 1998, 
2000; Cheranov and Jaggar, 2002). In the present re-
port, exposure of myotubes to various extracellular K+ 
concentrations had no strong effect on the RSD. Fur-
thermore, application of the L-type channel inhibitor, 
nifedipine, had no signifi  cant effect on the RSD param-
eter in Sol cells (unpublished data). Taken together, 
these results are in agreement with experiments from 
Shirokova et al. (1998) showing that in voltage control 
conditions, locations of spontaneous release were not 
sensitive to depolarization pulses in myotubes from pri-
mary culture. Hence, in Sol cell lines as well as in devel-
oping myotubes, SR calcium release channels involved 
in spontaneous events may not be sensitive to changes 
in membrane potential, suggesting uncoupling with 
DHPRs. Furthermore, whatever the imposed potential, 
RSD values obtained in SolD(+) never reached those in 
SolC1(−). This result suggests that control of calcium 
release event activities, in Sol cell lines, is clearly dissoci-
ated from electrical properties of the membrane.
Resting free calcium concentration in cells lacking 
dystrophin was shown higher than in normal cells in 
mdx mouse fi  bers (Turner et al., 1988), in muscle biop-
sies from DMD patients (Imbert et al., 1995) and in 
SolC1(−) myotubes (Marchand et al., 2004). Because 
of the known property of myoplasmic calcium ions to 
induce opening of SR calcium channels, RyRs (Conklin 
et al., 2000) and IP3Rs (Tovey et al., 2001), these data 
raised the question that the high calcium release event 
activity observed in SolC1(−) myotubes could be due to 
the high [Ca2+]i. Combined measurements of calcium 
levels and RSD were performed on BAPTA-loaded prep-
arations (Fig. 5). These experiments allowed us to dis-
play the density of events as a function of [Ca2+]i. As 
expected, at low concentrations of myoplasmic free cal-
cium, RSD was reduced. This reduction could be due to 
(a) reduced calcium concentration inside stores, (b) 
calcium channel inactivation, or (c) a reduction of the 
calcium-induced calcium release (CICR) mechanism. 
However, with increasing calcium, RSD increased up to 
a plateau and the levels reached at the plateau were sig-
nifi   cantly different between SolC1(−) and SolD(+). 
Furthermore, sigmoid patterns of RSD extinction were 
different between the dystrophin-defi  cient  SolC1(−) 
and the mini-dystrophin transfected SolD(+) cells. It is 
also worth noting that incubation with BAPTA-AM will 
not only reduce intracellular calcium concentration but 
will also add in the myoplasm a calcium chelator with 
high affi  nity, the BAPTA. The presence of this artifi  cial 
buffering component will consequently reduce Ca2+ in-
crease during the release from the SR, modifying cal-
cium channel gating properties and calcium-dependent 
inactivation effect. Consequences of these changes 
could then be the inhibition of CICR and the modifi  ca-
tion of a mechanism at the origin of spontaneous re-
lease events. Nevertheless, if the active buffering role of 
BAPTA may play in the reduction of the “RSD” parame-
ter, this reduction effect is related to calcium sensitivity 
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  between SolC1(−) and SolD(+) refl  ected  modifi  ca-
tions of the intrinsic properties of release channels 
when mini-dystrophin is expressed (SolD(+)) as com-
pared with when dystrophin is absent (SolC1(−)).
Morphometric analysis of calcium release events (Fig. 6) 
showed that the amplitude of spontaneous release 
from SolC1(−) and SolD(+) myotubes was not signifi  -
cantly different (0.82 and 0.80, respectively), indicating 
similar levels of Ca2+ stored in the SR in SolC1(−) and 
in SolD(+). Hence, differences in RSD observed be-
tween SolC1(−) and SolD(+) myotubes may not be 
due to different levels of stored calcium but to changes 
in the mechanism at the initiation of release activities or 
to a reduced CICR.
Calcium Channels Involved in Release Activities 
in Sol Myotubes
Isotypes I and III of the RyR family are known to con-
tribute to elementary calcium release events at rest in 
skeletal muscle cells (Shirokova et al., 1998; Rios et al., 
2001). In our experiments, the use of ryanodine at high 
concentrations signifi  cantly reduced RSD in Sol myo-
tubes. This reduction could be either attributed to a 
blockade of release through most RyRs or to calcium 
store depletion after partial opening of these calcium 
channels. With thapsigargin exposure, increased cal-
cium, refl  ecting the amount of calcium stored in the 
SR, was similar in ryanodine-treated and untreated cells 
(unpublished data). This result indicates that in these 
conditions, the main effect of ryanodine (100 μM for 
10 min) was the inhibition of RyR calcium channels. 
With ryanodine application, the reduction of RSD was dif-
ferent in SolC1(−) and SolD(+). Indeed, rare calcium 
release events were found in SolD(+) preparations, 
whereas a signifi  cant calcium release event activity was 
still observed in SolC1(−) myotubes. These results 
  suggest the presence of a calcium release mechanism, 
at rest, insensitive to ryanodine, which is more apparent 
in SolC1(−).
It has been clearly demonstrated in many cells that 
stimuli operate through phospholipase C to generate 
IP3 that induces Ca2+ release from internal store 
(Berridge, 1993). In smooth muscle cells, Ca2+ puffs 
evoked by activation of clusters of IP3Rs have been pre-
sented (Boittin et al., 2000), but in skeletal muscle cells, the 
role of IP3 pathway in resting calcium signaling is still 
poorly documented. Several studies from Jaimovich’s 
group, however, have shown that IP3Rs are involved in 
calcium signaling in developing skeletal muscle cells 
(Jaimovich et al., 2000; Powell et al., 2003). In our ex-
periments, the two IP3 pathway inhibitors, 2-APB and 
U73122, signifi  cantly reduced RSD in both cell types. 
This observation suggests that IP3Rs participate in cal-
cium release events occurring at rest in Sol cells. With 
application of 2-APB, a direct inhibitor of IP3R calcium 
channels, the stronger reduction of RSD was observed 
in SolC1(−) myotubes (88% decrease as compared with 
76% in SolD(+)). These results suggest that the IP3R-
related component of release activity is elevated when 
dystrophin is absent (SolC1(−)) and reduced when 
mini-dystrophin is expressed (SolD(+)). When this 
component is inhibited, both cell types displayed the 
same release event activity. These data enlighten the im-
portance of the IP3 signaling pathway in resting calcium 
signaling and homeostasis, particularly in dystrophin-
defi  cient skeletal muscle cells.
Cross-talk between RyRs and IP3Rs?
Previous studies demonstrated that Ca2+ sparks origi-
nating from the opening of RyRs in skeletal muscle dis-
played a duration (FDHM) of  30 ms (Shirokova et al., 
1999). Ca2+ puffs initiated by IP3Rs in Xenopus oocyte 
and in rat ureteric myocytes exhibited release events 
with duration between 200 and 250 ms (Berridge, 1997; 
Boittin et al., 2000). It has also been shown, in smooth 
muscle cells, that stimulation of the IP3 pathway in-
creased the duration of spontaneous release events 
(Zhang et al., 2003). In our experiments, duration (me-
dian) of release events was 64.5 ms and 55.2 ms in 
SolC1(−) and SolD(+) myotubes, respectively. Further-
more, numerous calcium events with duration >100 ms 
have been recorded in both myotubes, suggesting pat-
terns of release similar to the pattern of Ca2+ puffs. Pre-
vious studies hypothesized, in smooth muscle cells, a 
possible interaction between RyRs and IP3Rs and that 
Ca2+ release events could originate from a “cross-talk” 
between these channels (Gordienko and Bolton, 2002; 
Zhang et al., 2003). Thus, one can postulate that RyRs 
and IP3Rs might both participate in the initiation and 
propagation of resting events, leading to a mixture of 
sparks and puffs. Different contribution levels of these 
two channels could explain differences in RSD between 
SolC1(−) and SolD(+) myotubes.
Dystrophin Deﬁ  ciency and Calcium Signaling in Resting Cells
Three main results are of particular interest in this 
work. First, this study indicates a possible role, at rest, of 
local Ca2+ release from the SR in Ca2+ mishandling in 
dystrophin-defi  cient cells. Second, it strongly supports 
the hypothesis of a deregulation of Ca2+ release in a 
dystrophin-defi  cient cell line, which is attenuated by ex-
pression of mini-dystrophin. Finally, it establishes evi-
dence for a signifi  cant role of IP3Rs in spontaneous 
Ca2+ release events in dystrophin-defi  cient cells. Because 
these spontaneous events are known to contribute to 
the resting level of calcium (Berridge, 1997), these 
events could be involved in increased resting free 
  calcium, which leads to cell death. Hence, these results 
combined with our previous work (Balghi et al., 2006) 
provide evidence for the regulation by mini-dystrophin 
of an IP3 pathway, which is overactivated in dystrophin-
defi  cient cells. Expression of this protein, which is a   Balghi et al. 229
candidate for gene therapy, contributes both during 
stimulation and in resting condition to a more con-
trolled calcium homeostasis.
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